impact factor, citescore
logo
 

One year in review

 

Idiopathic inflammatory myopathies: one year in review 2024


1, 2, 3, 4, 5, 6, 7, 8, 9, 10

 

  1. Rheumatology Unit, University of Pisa, Italy.
  2. Department of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Italy.
  3. Rheumatology Department, Unidade Local de Saúde da Região de Aveiro; and Aveiro Rheumatology Research Centre, Egas Moniz Health Alliance, Aveiro, Portugal.
  4. Department of Internal Medicine and Therapeutics, Università di Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  5. Rheumatology, Department of Medicine and Surgery, University of Perugia, Italy.
  6. Rheumatology Unit, University of Pisa, Italy.
  7. Department of Neurology and Pain Treatment, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, and Department of Neurology, Neuromuscular Centre, University Medical Centre Göttingen, Germany.
  8. Rheumatology Unit, University of Pisa, Italy.
  9. Department of Internal Medicine and Therapeutics, Università di Pavia; and Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  10. Rheumatology Outpatient Clinic and Internal Medicine, Hospital of Livorno, Italy. simone.barsotti.pisa@gmail.com

CER18615
2025 Vol.43, N°2
PI 0167, PF 0177
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 40018744 [PubMed]

Received: 09/02/2025
Accepted : 19/02/2025
In Press: 26/02/2025
Published: 26/02/2025

Abstract

Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of autoimmune diseases characterised by skeletal muscle inflammation and frequently by other organs involvement, in particular lung and skin, but also joints, heart and gastrointestinal tract. Although they are rare diseases, the literature on IIMs has been growing rapidly and many studies have been published in order to clarify the pathogenesis and to better define diagnosis, clinical manifestations (muscular and extra-muscular) and treatment. The purpose of this review is to summarise the most relevant contributions published over the last year on this topic.

DOI: https://doi.org/10.55563/clinexprheumatol/yizkja

Rheumatology Article